GRIFOLS | GRF - Fremdkapital





Fremdkapital Veränderung Datum
Alcon AG USD 4.16B 434M 2026-03
Almirall EUR 324.81M 61.32M 2025-12
Amadeus IT EUR 2.54B 1.8M 2026-03
argenx SE USD 35.57M 3.05M 2025-06
AstraZeneca USD 25.96B 177M 2026-03
Bayer EUR 30.68B 1.15B 2026-03
Cie Automotive EUR 1.48B 58.65M 2025-12
Demant DKK 18.98B 3.71B 2025-12
Ence Energia y Celulosa EUR 509.58M 6.32M 2025-12
Essilor EUR 9.46B 92M 2025-12
Ferrovial EUR 9.36B 816M 2025-12
Fresenius EUR 9.22B 1.58B 2025-12
Fresenius Medical Care EUR 5.74B 895.27M 2026-03
Genmab DKK 5.14B 5.01B 2025-12
GlaxoSmithKline GBP 14.01B 696M 2026-03
GRIFOLS EUR 9.08B 612M 2026-03
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Inditex EUR 4.39B 463M 2025-12
Lakefront Biotherapeutics EUR 4.85M 335K 2026-03
Merck EUR 10.8B 72M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Philips EUR 6.89B 43M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
Smith & Nephew USD 3.3B 22M 2025-12
UCB EUR 2.18B 634M 2025-12
Viscofan EUR 67.83M 19.93M 2026-03